Table 2 FEV1 (L) at 16 hours post-dose after a single inhalation of either SFC (50/100 mcg), FBC (4.5/160 mcg) or placebo (Study A).
Placebo (n = 33) | SFC (n = 33) | FBC (n = 33) | |
|---|---|---|---|
Baseline adjusted mean (se) | 2.74 (0.04) | 3.01 (0.04) | 3.03 (0.04) |
Adjusted mean change at 16 hours from baseline (se) | -0.05 (0.04) | 0.22 (0.04) | 0.25 (0.04) |
SFC vs placebo | FBC vs placebo | ||
Statistical difference (se) | 0.27 (0.04) | 0.29 (0.04) | |
95% CI | 0.19, 0.35 | 0.21, 0.37 | |
P value | <0.001 | <0.001 | |
SFC vs FBC | |||
Statistical difference (se) | -0.02 (0.04) | ||
95% CI | -0.10, 0.06 | ||
P value | 0.617 |